Federated Hermes Inc. Purchases 1,307 Shares of Exponent, Inc. (NASDAQ:EXPO)

Federated Hermes Inc. increased its position in Exponent, Inc. (NASDAQ:EXPO) by 35.0% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,038 shares of the business services provider’s stock after purchasing an additional 1,307 shares during the period. Federated Hermes Inc.’s holdings in Exponent were worth $479,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of EXPO. GAMMA Investing LLC raised its holdings in Exponent by 67.7% during the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock worth $36,000 after buying an additional 153 shares during the last quarter. Benjamin F. Edwards & Company Inc. raised its holdings in shares of Exponent by 866.0% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 512 shares of the business services provider’s stock worth $42,000 after acquiring an additional 459 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in Exponent by 166.5% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock valued at $49,000 after purchasing an additional 323 shares during the last quarter. Janiczek Wealth Management LLC increased its holdings in Exponent by 293.7% during the 1st quarter. Janiczek Wealth Management LLC now owns 626 shares of the business services provider’s stock worth $52,000 after purchasing an additional 467 shares in the last quarter. Finally, YHB Investment Advisors Inc. bought a new stake in Exponent during the 1st quarter worth approximately $75,000. 92.37% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Truist Financial reaffirmed a “buy” rating and set a $120.00 target price (up previously from $100.00) on shares of Exponent in a research report on Friday, July 26th.

Exponent Price Performance

Shares of EXPO stock opened at $111.24 on Tuesday. The firm has a 50-day moving average of $105.56 and a 200-day moving average of $94.98. Exponent, Inc. has a one year low of $64.61 and a one year high of $113.00. The company has a market cap of $5.64 billion, a P/E ratio of 56.18 and a beta of 0.66.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.57 EPS for the quarter, beating the consensus estimate of $0.50 by $0.07. Exponent had a net margin of 19.35% and a return on equity of 28.39%. The firm had revenue of $132.43 million during the quarter, compared to analyst estimates of $130.83 million. During the same quarter last year, the business posted $0.50 EPS. The company’s revenue for the quarter was up 2.1% on a year-over-year basis. As a group, research analysts expect that Exponent, Inc. will post 2.04 earnings per share for the current fiscal year.

Exponent Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 20th. Shareholders of record on Friday, September 6th were given a $0.28 dividend. The ex-dividend date was Friday, September 6th. This represents a $1.12 annualized dividend and a yield of 1.01%. Exponent’s dividend payout ratio is currently 56.57%.

Insider Buying and Selling at Exponent

In related news, VP John Pye sold 3,956 shares of the business’s stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $105.00, for a total value of $415,380.00. Following the transaction, the vice president now directly owns 28,422 shares of the company’s stock, valued at approximately $2,984,310. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 2.10% of the company’s stock.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.